Alloy vs Näky
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
Näky
Best for patients comfortable with intake-gated pricing who want access to compounded oral semaglutide drops or an explicit microdose program alongside a longevity menu (NAD+ / Sermorelin)Side-by-Side Comparison
| Feature | Alloy | Näky |
|---|---|---|
| Overall Score | ✓7.4/10 | 7.0/10 |
| Starting Price | $80/mo | — |
| Editorial Rating | ✓3.7 ★ /5 | 3.5 ★ /5 |
| Features | 8 features | ✓9 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
Näky
Pros
- ✓LegitScript Approved seal verbatim displayed ('Verify LegitScript Approval for www.benaky.com')
- ✓Oral semaglutide DROPS as a distinct product line — uncommon among compounded GLP-1 telehealth
- ✓Explicit GLP-1 Microdose program offered as a separate SKU
- ✓Multi-modality menu (NAD+, Sermorelin) for patients seeking longevity stack alongside GLP-1
- ✓3-minute online assessment + same-day treatment plan disclosed publicly
- ✓NAKY10 promo code referenced for oral semaglutide product line
Cons
- ✗Steady-state monthly pricing for compounded semaglutide and tirzepatide NOT disclosed publicly — gated behind intake
- ✗Oral semaglutide drops pricing NOT disclosed
- ✗GLP-1 Microdose program pricing NOT disclosed
- ✗Specific legal entity name + state of incorporation NOT publicly disclosed
- ✗Partner FDA-regulated pharmacy name NOT disclosed (only generic 'USA Based FDA-Regulated pharmacies' claim)
- ✗Per-state availability NOT enumerated
- ✗Brand-name GLP-1 lineup (Wegovy/Zepbound/Mounjaro/Ozempic/Foundayo) NOT addressed — compounded only
- ✗/treatments/<slug> and /pricing routes return 404 — pricing tiers genuinely intake-gated
- ✗Initial consultation fee structure NOT disclosed publicly
- ✗Lab work + ongoing-care touchpoints NOT clearly disclosed in marketing copy
- ✗**Oral semaglutide DROPS** are not the same as Rybelsus or any FDA-approved oral semaglutide formulation — patients should ask for specific bioavailability + dose-equivalence framing during the intake; we do not endorse compounded oral GLP-1 drops as bioequivalent to FDA-approved alternatives without primary-source verification
Our Verdict
Alloy edges out Näky with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. Näky remains a solid alternative, especially if you're looking for patients comfortable with intake-gated pricing who want access to compounded oral semaglutide drops or an explicit microdose program alongside a longevity menu (NAD+ / Sermorelin).
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.